Clinical and pathological features affecting cardiac sympathetic denervation in autopsy-confirmed dementia with Lewy

M Takahashi1, T Uchihara2,3, M Yoshida4

  • 1Department of Neurology, Kanto Central Hospital of the Mutual Aid Association of Public-School Teachers, Tokyo, Japan.

Insights

Dementia with Lewy bodies (DLB) patients often have mild cardiac sympathetic nerve (CSN) degeneration. Early psychological symptoms and Alzheimer's pathology may indicate preserved CSN function in DLB.

Area of Science:

  • Neurology
  • Cardiology
  • Pathology

Background:

  • Dementia with Lewy bodies (DLB) is a neurodegenerative disease characterized by Lewy bodies in the brain.
  • Cardiac sympathetic denervation is a common feature in DLB, but factors influencing its severity are not fully understood.

Purpose of the Study:

  • To investigate the clinical and neuropathological features associated with cardiac sympathetic denervation in autopsy-confirmed DLB patients.
  • To identify factors that may predict the degree of residual cardiac sympathetic nerve (CSN) axons in DLB.

Main Methods:

  • Autopsy-confirmed DLB patients (n=54) were analyzed.
  • Cardiac tissue (left ventricular anterior wall) was immunostained for tyrosine hydroxylase to quantify residual CSN axons.
  • Relationships between residual CSN axon levels and clinical/neuropathological features were examined.

Main Results:

  • Nearly all DLB patients exhibited minimal residual CSN axons (<2.0% in 92.6%).
  • Patients with early psychological symptoms had significantly more residual CSN axons (1.50% vs. 0.40%).
  • Preserved CSN axons were associated with shorter disease duration, neocortical Lewy body pathology, and concomitant Alzheimer's disease pathology.

Conclusions:

  • Mild cardiac sympathetic denervation is common in DLB.
  • Early psychological symptoms, shorter disease duration, and co-existing Alzheimer's pathology may be linked to less severe CSN degeneration in DLB.
  • DLB patients with widespread early Lewy body pathology may present with milder cardiac sympathetic nerve degeneration.
Abstract

Related Concept Videos

Neural Regulation01:37

Neural Regulation

Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
42.9K
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
1.6K
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
1.5K
Dementia01:30

Dementia

Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
455
Lysosomal Hydrolases01:22

Lysosomal Hydrolases

Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
862